Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

PharmaCorp to Acquire Two Pharmacies in Western Canada

(NASDAQ:PCRX) SASKATOON, Saskatchewan, Sept. 03, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that it has entered into defin...

How does this expansion compare to recent moves by competing pharmacy chains in Canada, and what implications does it have for PCRX's market share and stock valuation? What revenue and cost synergies are expected from the two pharmacy acquisitions, and how will they affect PCRX's earnings guidance? How will the acquisition be financed and what dilution impact will it have on existing shareholders?
Symbol: PCRX
Mergers
10 days ago
Read more globenewswire

ByteDance and HTC Settled ITC Dispute with IngenioSpec on VR/XR Headsets

(HTC) WACO, Texas--(BUSINESS WIRE)--IngenioSpec Resolve Patent Dispute with ByteDance and HTC on VR/XR Headset Technology.

Will the settlement lead to any licensing fee reductions or cost synergies that could influence HTC's stock valuation and investor sentiment? What implications does the resolution have for HTC's competitive positioning against other VR/XR headset manufacturers such as Meta, Sony, and Apple? How will the settlement of the ITC dispute affect HTC's revenue and profit forecasts in the coming quarters?
Symbol: HTC
Lawsuits
10 days ago
Read more businesswire

Apple has survived Trump's tariffs so far. It might raise iPhone prices anyway

(NASDAQ:AAPL) As Apple prepares to unveil the iPhone 17, some analysts expect the company to raise prices even after all CEO Tim Cook has done to avoid the worst of tariffs.

How might Apple’s pricing strategy compare to competitors like Samsung and Google in the upcoming quarter? What is the likelihood that new tariffs or trade policy changes could further impact Apple’s supply chain costs? How will a potential iPhone price increase affect Apple’s sales volume and revenue forecasts?
Symbol: AAPL
Regulation
10 days ago
Read more cnbc_tech

Roivant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients

(NASDAQ:IMVT) NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune disea...

What are the projected timelines for regulatory approval, commercialization, and reimbursement for batoclimab, and how could these factors impact long‑term earnings forecasts? What comparative advantages does batoclimab have over existing or pipeline therapies for uncontrolled Graves' disease, and how might this affect market share potential? How will the six‑month off‑treatment remission data for batoclimab influence IMVT's valuation and short‑term stock momentum?
Symbol: IMVT
Clinical trials
10 days ago
Read more globenewswire

EPH European Property Holdings PLC Profit / Loss Warning - EPH expects net profit in its consolidated accounts for the 1HY 2025 compared to the previous year

(EPH) 03 September 2025, Limassol, Cyprus / Ad hoc announcement pursuant to Art. 53 LR

How does this earnings outlook compare to peer performance and the broader European property sector? What are the underlying drivers behind the profit decline and are they temporary or structural? How will the 1H 2025 net profit warning affect EPH's valuation multiples and price targets?
Symbol: EPH
Earnings
10 days ago
Read more globenewswire

Euronext announces share repurchase programme as part of its long-term incentive plan   

(ENX) Euronext announces share repurchase programme as part of its long-term incentive plan

How does this buyback compare to recent repurchase activities by peer exchanges and what could be the impact on ENX's valuation multiples? What is the source of funding for the buyback and how might it affect Euronext's balance sheet and credit metrics? How large is the share repurchase programme and what is the expected timeline for execution?
Symbol: ENX
Buybacks
10 days ago
Read more globenewswire